Glenmark launches SUTIB (Sunitinib) – priced 96% lower than the innovator brand. Reduces the risk of kidney cancer progression by 58%
Glenmark Pharmaceuticals, a research-led, global integrated...
Browse Tag
Sunitinib
1 Article